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 vascular leakage, stabilization of lysosomes and cathepsin  inhibition 
(Poupko et al., 2007). These actions of anisodamine resulted in the 
ultimate improvement of blood flow in the microcirculation, which 
is the main mechanism proposed in the textbook of Pharmacology.
 Ruan et al. (2001) found that anisodamine was able to counteract 
endothelial cell activation by inhibiting  lipopolysaccharide-induced 
plasminogen activator inhibitor-1 and tissue factor expression pos-
sibly through the NF-κB pathway, and suggested that the ability of 
anisodamine to counteract lipopolysaccharide effects on endothe-
lial cells might be one underlying mechanism for its efficacy in the 
treatment of bacteremic shock. It is interesting because NF-κB is 
a key role in inflammatory diseases, which is able to regulate the 
synthesis of pro-inflammatory cytokines, such as tumor necro-
sis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, and 
IL-8 (Baldwin, 1996; Tak and Firestein, 2001). These suggested 
that the anti-shock effect of anisodamine might be related to 
anti-inflammation.
 The cholinergic anti-inflammatory pathway was a recently pro-
posed pathway, which links the vagus nerve and immune system 
through α7 nicotinic acetylcholine receptor (α7nAChR). That is, 
the vagus nerve can modulate the immune response and inhibit 
inflammation through a physiological mechanism, which can 
be translated into a pharmacological strategy. Acetylcholine, the 
principal neurotransmitter of the vagus nerve, signaling through 
α7nAChR, can inhibit the production of pro-inflammatory 
cytokines from macrophages (Libert, 2003; Wang et al., 2003; 
Figure 3). Our previous study evaluated the effect of anisodamine, 
the muscarinic receptor antagonist, in rodent models of endotoxic 
shock. We hypothesized that blocking muscarinic receptor with 
anisodamine resulted in rerouting of acetylcholine to α7nAChR 
bringing about increased acetylcholine-mediated activation of 
α7nAChR and the cholinergic anti-inflammatory pathway. It was 
found that methyllycaconitine (an selective α7nAChR antagonist) 
significantly antagonized the beneficial effect of anisodamine on 
 Anisodamine, a belladonna alkaloid isolated from the Chinese 
medicinal herb Scopolia tangutica Maxim (Figure 1) of the 
Solanaceae family indigenous to Tibet and first synthesized by 
Chinese scientists in 1975, is an ester formed by the combination 
of tropic acid and the organic base tropine, and is related to atro-
pine with a hydroxyl group at the asymmetric carbon position six 
of the tropine radical (Figure 2). It is generally considered as an 
antagonist of muscarinic receptor in the textbook of Pharmacology 
for medical students in China (Yang and Su, 2008), and has been 
used therapeutically to improve blood flow in circulatory disorders 
such as septic shock and disseminated intravascular coagulation 
since 1965. Studies found that anisodamine significantly reduced 
the mortality rate of toxic bacillary dysentery from 20–30 to 0.5% 
and fulminant epidemic meningitis from 66.9 to 12.4% in humans 
(Anonymous, 1975; Wang and Kuo, 1978; Xiu, 1980). In different 
kinds of shock models prepared from either rabbit, or cat, or rat, 
induced by late hemorrhage, superior mesenteric artery occlusion, 
septic shock from peritonitis, and traumatic shock, anisodamine 
significantly alleviated the progress of shock and increased the sur-
vival rate of the animals than that of other commonly used vasoac-
tive drugs, such as norepinephrine, phenoxybenzamine, dopamine, 
and aramine (Hock et al., 1983; Su et al., 1983, 1984).
 Various mechanisms for the anti-shock action of anisodamine 
were proposed. As a vasodilator, it was believed to be a valuable 
adjunct to the resuscitation regime of burn shock, and a promising 
drug to abate endogenous endotoxemia subsequent to splanchnic 
vasoconstriction due to hypovolemia in burn patients (Sheng et al., 
1997). It was also demonstrated that the efficacy of anisodamine 
in bacteremic shock was mediated by inhibition of granulocyte, 
and platelet aggregation and thromboxane synthesis (Xiu et al., 
1982), and anisodamine protected tissues from reperfusion dam-
age by inhibition of thromboxane synthesis after resuscitation in 
burn shock patients (Huang et al., 1990). Other possible mecha-
nisms included fibrinolytic effects, reversal of endotoxin induced 
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pursued by stimulation of the vagus nerve or α7nAChR but also 
by inhibition of muscarinic receptors, which results in secondary 
activation of the cholinergic anti-inflammatory pathway (Liu et al., 
2009; van Westerloo, 2009; Figure 3). We also found that α7nAChR 
played an important role in the organ damage in spontaneously 
hypertensive rats (SHRs), and chronic treatment of SHRs with the 
α7nAChR agonist PNU-282987 relieved end organ damage and 
inhibited tissue levels of pro-inflammatory cytokines involved the 
NF-κB pathway (Li et al., 2011). These suggest that the cholinergic 
anti-inflammatory pathway might act, at least partly, through the 
NF-κB pathway, and anisodamine can indirectly activate the cholin-
ergic anti-inflammatory pathway by blocking muscarinic receptor.
 In summary, we suggest that the beneficial effect of anisodamine 
in shock involves the cholinergic anti-inflammatory pathway, which 
expands the possibilities of using the cholinergic anti-inflammatory 
pathway for clinical benefit. However, further studied are needed 
on the molecular and preclinical level.
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FiguRe 1 | The Chinese medicinal herb Scopolia tangutica Maxim.
FiguRe 2 | Chemical structures of anisodamine and atropine.
FiguRe 3 | Action mode of anisodamine in cholinergic anti-inflammatory 
pathway.
mean arterial pressure and TNF-α, interleukin-1β expression 
in response to lipopolysaccharide; the anti-shock effects of ani-
sodamine were markedly attenuated in vagotomized mice and 
α7nAChR−/− mice; in vitro, anisodamine significantly augmented 
the effect of acetylcholine on fluorescence intensity stained with 
fluorescein isothiocyanate-labeled-α-bungarotoxin and TNF-α 
production stimulated with lipopolysaccharide. Our results sug-
gest that activation of the vagal immune reflex can not only be 
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